Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS)

 
SNSS Technical Analysis
2
As on 31st Oct 2017 SNSS Share Price closed @ 2.56 and we RECOMMEND Sell for LONG-TERM with Stoploss of 3.18 & Strong Buy for SHORT-TERM with Stoploss of 2.14 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

SNSS Share Price

Open 2.23 Change Price %
High 2.65 1 Day 0.41 19.07
Low 2.16 1 Week 0.00 0.00
Close 2.56 1 Month 0.34 15.32
Volume 661722 1 Year -1.51 -37.10
52 Week High 4.45 | 52 Week Low 1.82
 
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
MU 44.31 6.39%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
INTC 45.49 2.52%
 
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
SCHS 0.04 33.33%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
HLIT 3.70 25.42%
OTT 2.39 25.13%
QNST 8.90 20.76%
VRTA 4.00 19.40%
SNSS 2.56 19.07%
GCFB 0.44 18.92%
 
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
GMETP 0.15 -76.92%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
 
 
SNSS
Daily Charts		 SNSS
Intraday Charts		 Whats New @
Bazaartrend		 SNSS
Free Analysis
 
SNSS Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
RESISTANCE3.01
RESISTANCE2.83
SUPPORT2.29
SUPPORT2.11
SUPPORT0.00
SUPPORT0.00
 
SNSS Target for Month November
Share
4th UP TARGET4.16
3rd UP TARGET3.65
2nd UP TARGET3.33
1st UP TARGET3.01
1st DOWN TARGET2.11
2nd DOWN TARGET1.79
3rd DOWN TARGET1.47
4th DOWN TARGET0.96
 
SNSS Weekly Target
4th UP TARGET0.00
3rd UP TARGET0.00
2nd UP TARGET0.00
1st UP TARGET0.00
1st DOWN TARGET0.00
2nd DOWN TARGET0.00
3rd DOWN TARGET0.00
4th DOWN TARGET0.00
 
SNSS Target for Year 2020
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
 
SNSS Other Details
Segment EQ
Market Capital 190775152.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
SNSS Address
SNSS
 395 Oyster Point Boulevard
Suite 400
South San Francisco, CA 94080
United States
Phone: 650-266-3500
Fax: 650-266-3501
 
SNSS Latest News
 
Your Comments and Response on Sunesis Pharmaceuticals, Inc.
 
SNSS Business Profile
Sunesis Pharmaceuticals, Inc. (Sunesis) is a biopharmaceutical company focused on the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers. The Company is focuses primarily on the development of vosaroxin for the treatment of acute myeloid leukemia (AML). Vosaroxin is a anti-cancer quinolone derivative (AQD). AQDs have been shown to mediate anti-tumor activity by targeting mammalian topoisomerase II, an enzyme critical for cell replication. The Company owns worldwide development and commercialization rights to vosaroxin. The Company�s VALOR trial is designed to evaluate the effect of vosaroxin in combination with cytarabine, chemotherapy in AML. The trial has an adaptive design and is based on data from the Company's Phase II clinical trial of vosaroxin in combination with cytarabine in relapsed or refractory AML.
 
© 2005-2019 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service